EE200100530A - Meetod bioloogiliselt aktiivse molekuli valmistamiseks, sel viisil saadud molekul ning molekuli muteerunud prekursorit kodeeriv cDNA - Google Patents

Meetod bioloogiliselt aktiivse molekuli valmistamiseks, sel viisil saadud molekul ning molekuli muteerunud prekursorit kodeeriv cDNA

Info

Publication number
EE200100530A
EE200100530A EEP200100530A EEP200100530A EE200100530A EE 200100530 A EE200100530 A EE 200100530A EE P200100530 A EEP200100530 A EE P200100530A EE P200100530 A EEP200100530 A EE P200100530A EE 200100530 A EE200100530 A EE 200100530A
Authority
EE
Estonia
Prior art keywords
molecule
preparing
biologically active
cdna encoding
mutated precursor
Prior art date
Application number
EEP200100530A
Other languages
English (en)
Inventor
Rubinstein Menachem
Liu Bianling
Novick Daniela
Dinarello Charles
Graber Pierre
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of EE200100530A publication Critical patent/EE200100530A/et
Publication of EE05591B1 publication Critical patent/EE05591B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
EEP200100530A 1999-04-13 2000-04-13 Meetod bioloogiliselt aktiivse tstokiini valmistamiseks ja bioloogiliselt aktiivse tstokiini muteerunud prekursorit kodeeriv cDNA EE05591B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL12942799A IL129427A0 (en) 1999-04-13 1999-04-13 Preparation of biologically active molecules
PCT/IL2000/000220 WO2000061768A2 (en) 1999-04-13 2000-04-13 Preparation of biologically active molecules

Publications (2)

Publication Number Publication Date
EE200100530A true EE200100530A (et) 2002-12-16
EE05591B1 EE05591B1 (et) 2012-10-15

Family

ID=11072700

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100530A EE05591B1 (et) 1999-04-13 2000-04-13 Meetod bioloogiliselt aktiivse tstokiini valmistamiseks ja bioloogiliselt aktiivse tstokiini muteerunud prekursorit kodeeriv cDNA

Country Status (24)

Country Link
US (1) US7098002B1 (et)
EP (1) EP1169460B1 (et)
JP (1) JP4822587B2 (et)
KR (1) KR100682185B1 (et)
CN (1) CN1324140C (et)
AR (1) AR023468A1 (et)
AT (1) ATE326536T1 (et)
AU (1) AU781342B2 (et)
BR (1) BR0009782A (et)
CA (1) CA2368994C (et)
DE (1) DE60028022T2 (et)
DK (1) DK1169460T3 (et)
EA (1) EA006825B1 (et)
EE (1) EE05591B1 (et)
ES (1) ES2259287T3 (et)
HK (1) HK1044351A1 (et)
IL (3) IL129427A0 (et)
MX (1) MXPA01010487A (et)
NO (1) NO329525B1 (et)
PT (1) PT1169460E (et)
SI (1) SI1169460T1 (et)
UA (1) UA73940C2 (et)
WO (1) WO2000061768A2 (et)
ZA (1) ZA200108364B (et)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001029232A2 (en) * 1999-10-20 2001-04-26 Scios Inc. Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage
US7273722B2 (en) 2000-11-29 2007-09-25 Allergan, Inc. Neurotoxins with enhanced target specificity
SI1392830T1 (sl) 2001-03-08 2006-06-30 Ares Trading Sa Mutanti interlevkina-18, njihova proizvodnja in uporaba
IL142246A0 (en) * 2001-03-26 2002-03-10 Applied Research Systems Method and kit for quantitation of polypeptides
WO2003068802A2 (en) 2002-02-11 2003-08-21 Zymogenetics, Inc. Materials and methods for preparing dimeric growth factors
WO2004074488A1 (en) * 2003-02-21 2004-09-02 Biotecnol S.A. Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions
US7824885B2 (en) * 2003-08-06 2010-11-02 University Of Maryland, College Park Engineered proteases for affinity purification and processing of fusion proteins
JP2007512008A (ja) * 2003-11-24 2007-05-17 ノボ　ノルディスク　アクティーゼルスカブ 融合タンパク質及び該タンパク質の切断方法
CA2558811A1 (en) 2004-03-08 2005-09-22 Zymogenetics, Inc. Dimeric fusion proteins and materials and methods for producing them
WO2008008082A2 (en) * 2005-09-19 2008-01-17 Allergan, Inc. Clostridial toxin activatable clostridial toxins
EP2014676B1 (en) * 2006-04-20 2012-03-07 Kringle Pharma Inc. Hgf precursor protein mutant and activated form thereof
DE102007008596B4 (de) * 2007-02-15 2010-09-02 Friedrich-Schiller-Universität Jena Biologisch wirksame Moleküle auf Grundlage von PNA und siRNA, Verfahren zu deren zellspezifischen Aktivierung sowie Applikationskit zur Verabreichung
CA3128656A1 (en) 2007-08-22 2009-02-26 The Regents Of The University Of California Activatable binding polypeptides and methods of identification and use thereof
WO2009044988A1 (en) * 2007-10-01 2009-04-09 Korea Research Institute Of Bioscience And Biotechnology Method for large scale preparation of procaspases, which can be artificially activated, in e. coli expression system and their activation
DE102009043743B4 (de) 2009-03-13 2016-10-13 Friedrich-Schiller-Universität Jena Zellspezifisch wirksame Moleküle auf Grundlage von siRNA sowie Applikationskits zu deren Herstellung und Verwendung
RU2636046C2 (ru) 2009-01-12 2017-11-17 Сайтомкс Терапьютикс, Инк Композиции модифицированных антител, способы их получения и применения
EP2398494A4 (en) 2009-02-23 2015-10-28 Cytomx Therapeutics Inc Proproteins and their methods of use
CN103923897B (zh) * 2013-01-11 2016-06-01 中国人民解放军军事医学科学院生物工程研究所 caspase重组酶原及其编码基因与应用
CN103388001B (zh) * 2013-07-16 2016-01-20 中国人民解放军第四军医大学 一种含凝血酶切割位点gst膜型表达载体及转染阳性细胞的方法
EP3083977B1 (en) 2013-12-20 2018-02-28 F. Hoffmann-La Roche AG Improved recombinant polypeptide production methods
KR20230048162A (ko) 2015-03-30 2023-04-10 그린라이트 바이오사이언시스, 아이엔씨. 리보핵산의 무세포 생산
IL302486A (en) 2015-06-24 2023-06-01 Hoffmann La Roche Antibodies against the transnephrine receptor with adapted affinity
PE20231655A1 (es) 2015-10-02 2023-10-17 Hoffmann La Roche Anticuerpos biespecificos contra el cd20 humano y el receptor de transferrina humano y metodos de uso
AR106189A1 (es) 2015-10-02 2017-12-20 Hoffmann La Roche ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
WO2017176963A1 (en) 2016-04-06 2017-10-12 Greenlight Biosciences, Inc. Cell-free production of ribonucleic acid
MX2020003841A (es) 2017-10-11 2020-11-06 Greenlight Biosciences Inc Métodos y composiciones para la producción de nucleósido trifosfatos y ácidos ribonucleicos.
KR20200080749A (ko) * 2018-12-27 2020-07-07 주식회사 폴루스 N-말단의 메티오닌이 절단된 목적 단백질 발현용 유전자 발현 카세트 및 이를 이용하여 n-말단의 메티오닌이 절단된 목적 단백질을 생산하는 방법
EP4013857A1 (en) * 2019-08-13 2022-06-22 King's College London Immunoresponsive cells armoured with spatiotemporally restricted activity of cytokines of the il-1 superfamily

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824297A (en) * 1990-06-25 1998-10-20 Oncogene Science, Inc. Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
AU659412B2 (en) * 1990-06-25 1995-05-18 Osi Pharmaceuticals, Inc. Tissue-derived tumor growth inhibitors
EP0533350B1 (en) * 1991-08-16 1999-05-26 Merck & Co. Inc. DNA encoding precursor interleukin 1B converting enzyme
JP3404038B2 (ja) 1991-12-31 2003-05-06 ザイモジェネティクス，インコーポレイティド トロンビンの製造方法
JPH06125784A (ja) * 1992-01-17 1994-05-10 Takeda Chem Ind Ltd モノクローナル抗体，ハイブリドーマ，その製造法および用途
US6303369B1 (en) * 1993-09-30 2001-10-16 Carl Spana Protein expression system
JP2000502903A (ja) 1995-12-29 2000-03-14 インサイト・ファーマスーティカルズ・インコーポレイテッド インターフェロンγ誘導因子―２をコードする核酸
JP4059941B2 (ja) * 1996-08-26 2008-03-12 社団法人芝蘭会 Ｒｈｏ標的タンパク質ｐ１４０ｍＤｉａ
AT405516B (de) * 1997-02-27 1999-09-27 Immuno Ag Faktor x-analoge mit modifizierter proteasespaltstelle
JPH10327872A (ja) * 1997-05-30 1998-12-15 Otsuka Pharmaceut Co Ltd Ｂｃｌ−２相互作用蛋白遺伝子ｂｉｓ
CA2295957C (en) 1997-08-07 2009-09-22 Toray Industries, Inc. Canine interleukin 18, canine interleukin 1.beta. converting enzyme, dna sequences encoding these, interleukin 18 production method and canine immune disease remedy

Also Published As

Publication number Publication date
EP1169460B1 (en) 2006-05-17
SI1169460T1 (sl) 2006-08-31
MXPA01010487A (es) 2002-05-06
IL129427A0 (en) 2000-02-17
ZA200108364B (en) 2002-10-11
WO2000061768A3 (en) 2001-02-08
CN1324140C (zh) 2007-07-04
ATE326536T1 (de) 2006-06-15
JP2002541813A (ja) 2002-12-10
BR0009782A (pt) 2002-01-08
CN1353761A (zh) 2002-06-12
NO20014966D0 (no) 2001-10-12
HK1044351A1 (en) 2002-10-18
EA200101078A1 (ru) 2002-04-25
IL145842A (en) 2008-06-05
UA73940C2 (uk) 2005-10-17
IL145842A0 (en) 2002-07-25
CA2368994C (en) 2010-03-09
KR100682185B1 (ko) 2007-02-12
CA2368994A1 (en) 2000-10-19
PT1169460E (pt) 2006-07-31
DK1169460T3 (da) 2006-09-18
EP1169460A2 (en) 2002-01-09
US7098002B1 (en) 2006-08-29
DE60028022D1 (de) 2006-06-22
JP4822587B2 (ja) 2011-11-24
AR023468A1 (es) 2002-09-04
NO329525B1 (no) 2010-11-01
EA006825B1 (ru) 2006-04-28
AU3985100A (en) 2000-11-14
AU781342B2 (en) 2005-05-19
KR20020007365A (ko) 2002-01-26
ES2259287T3 (es) 2006-10-01
NO20014966L (no) 2001-12-11
DE60028022T2 (de) 2006-09-28
EE05591B1 (et) 2012-10-15
WO2000061768A2 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
EE200100530A (et) Meetod bioloogiliselt aktiivse molekuli valmistamiseks, sel viisil saadud molekul ning molekuli muteerunud prekursorit kodeeriv cDNA
HK1052000A1 (en) Process of preparing tolterodine and analogues there of as well as intermediates prepared in the process.
HK1044338A1 (en) 5-Pyridyl-1, 3-azole compounds, process for producing the same and use thereof
PT2206702E (pt) Composto bicíclico, sua produção e utilização
ATE246270T1 (de) Rhodium-elektrokatalysator und dessen herstellungsverfahren
DE60002526D1 (de) Herstellung von Tricyclodecandicarbaldehyd, Pentacyclopentadecandicarbaldehyd und der entsprechenden Dimethanole
EE200100574A (et) Uued ühendid, nende valmistamise meetod ning kasutamine
EP1223163A4 (en) PROCESS FOR PRODUCTION OF ACRYLONITRILE, CATALYST USAGE AND METHOD OF PREPARATION THEREOF
PL377069A1 (pl) Porowata kształtka z węglika krzemu, proces jej wytwarzania oraz struktura komórkowa podobna do plastra pszczelego
EP1223162A4 (en) A METHOD FOR THE PRODUCTION OF ACRYLONITRILE, A CATALYST FOR THIS USE AND A METHOD FOR THE PRODUCTION THEREOF
ATE327257T1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher komplex von orthokieselsäure und prozess zur dessen herstellung
HUP0300589A3 (en) Production of fluormethyl 2,2,2-trifluoro-1-(trifluoromethyl) ethyl ether
AU2001291865A1 (en) Silicon-boron-carbon-nitrogen ceramics and precursor compounds, methods for the production and use thereof
EE200100573A (et) Uued ühendid, nende valmistamise meetod ning kasutamine
HK1040984A1 (zh) 製備d，l-薄荷醇的方法
HUP0204187A3 (en) Process for the preparation of 1-oxo-1,3-dihydro-5-isobenzofurancarboxylic acid and its use for the production of citalopram
AU7647400A (en) Surface finished concrete blocks, method for the production and use thereof
EP1593653A4 (en) PROCESS FOR PRODUCING SUPERCONDUCTING OXIDE, SUPERCONDUCTING OXIDE, AND SUBSTRATE AS SUPPORT FOR ITS PRECURSOR
PL359290A1 (en) Construction element and use of a support, and method for the production of an element for a facade
ITMI992048A0 (it) Procedimento stereoselettivo per la preparazione di endo-3-amminoazabi cicloalcani
ZA200007344B (en) Rotary trowel for use in the molding of ceramics and method for production thereof.
HK1039611A1 (en) Method for the pressureless production of alpha, alpha-dimethylphenyl acetic acid from alpha, alpha-dimethyl benzyl cyanide
IT1308175B1 (it) Procedimento ed impianto per l'ottenimento di filoncini di pasta conestremita' rastremate per la formazione di baguettes.
IL144093A0 (en) Use of heterogeneous catalysts in methods for the production of polyamides
IL139012A0 (en) Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds

Legal Events

Date Code Title Description
HH1A Change of representative
MM4A Lapsed by not paying the annual fees

Effective date: 20170413